Skip to main content

Table 1 Baseline characteristics of identified subjects

From: Quantitative proteomics by iTRAQ-PRM based reveals the new characterization for gout

Items

Control (N = 8)

Acute Gout (N = 8)

Gout Remission (N = 7)

Asymptomatic Hyperuricemia (N = 7)

Male(n)

2

8

6

6

Age (year)

28.38 ± 1.97

50.13 ± 3.92*

44.57 ± 7.19

38.57 ± 6.34

Serum UA (μmol/L)

273.0 ± 19.90

550.3 ± 45.17***

498.1 ± 55.78***

509.2 ± 19.53***

SCr (μmol/L)

59.86 ± 5.60

86.44 ± 6.92

106.8 ± 19.84*

107.5 ± 12.09*

BUN (mmol/L)

4.49 ± 0.24

4.80 ± 0.41

5.40 ± 1.14

5.93 ± 0.53

TC (mmol/L)

4.81 ± 0.13

4.21 ± 0.31

4.00 ± 0.21

4.64 ± 0.39

TG (mmol/L)

0.74 ± 0.05

1.84 ± 0.37

1.80 ± 0.22

2.33 ± 0.67*

HDL-C (mmol/L)

1.80 ± 0.10

0.95 ± 0.075***

0.98 ± 0.08***

1.18 ± 0.14***

LDL-C (mmol/L)

2.42 ± 0.08

2.42 ± 0.25

2.28 ± 0.26

2.64 ± 0.38

Hypertension(n)

0

3

3

2

  1. Data present mean ± SD (minimum–maximum)
  2. UA Uric acid, SCr The serum level of creatinine, BUN Blood urea nitrogen, TC Total cholesterol, TG Total glycerides, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol
  3. P values were calculated by using χ2 test for gender, hypertension and one-way ANOVA test for others (*, p < 0.05; **, p < 0.01; ***, p < 0.001)